Molecular Partners AG (MOLN) Discusses Clinical Imaging and Dosimetry Data for DLL3 Targeting Radiotherapeutic MPO712 Transcript [Seeking Alpha]
Molecular Partners AG - American Depositary Shares (MOLN)
Company Research
Source: Seeking Alpha
Company Participants Seth Lewis - Senior Vice President of Investor Relations, Communications & Strategy Patrick Amstutz - Co-Founder, CEO, Member of Management Board & Director Michael Stumpp - Co-Founder, Executive VP of Projects & Member of Management Board Philippe Legenne - Chief Medical Officer & Member of the Management Board Conference Call Participants Ken Herrmann Yue-Wen Zhu - LifeSci Capital, LLC, Research Division Chiara Montironi - Kempen & Co. N.V., Research Division William Maughan - Clear Street LLC., Research Division Michael Nedelcovych - TD Cowen, Research Division Joris Zimmermann - Octavian AG, Research Division Presentation Operator Good day, and welcome to the Molecular Partners call and webcast. [Operator Instructions] As a reminder, this call may be recorded. I would now like to turn the call over to Seth Lewis, Head of Investor Relations and Strategy. Please go ahead. Seth Lewis Senior Vice President of Investor Relations, Co
Show less
Read more
Impact Snapshot
Event Time:
MOLN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MOLN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MOLN alerts
High impacting Molecular Partners AG - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
MOLN
News
- Molecular Partners Highlights Favorable MP0712 DLL3 Radiotherapeutic Imaging, U.S. Phase I/II Ready [Yahoo! Finance]Yahoo! Finance
- Molecular Partners Announces Presentation of First Imaging and Dosimetry Data of DLL3-Targeting Radiotherapy MP0712 in Patients at TWC 2026 [Yahoo! Finance]Yahoo! Finance
- Molecular Partners Announces Presentation of First Imaging and Dosimetry Data of DLL3-Targeting Radiotherapy MP0712 in Patients at TWC 2026GlobeNewswire
- Molecular Partners (NASDAQ:MOLN) was upgraded by analysts at HC Wainwright to a "strong-buy" rating.MarketBeat
- Molecular Partners (NASDAQ:MOLN) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.MarketBeat
MOLN
Sec Filings
- 2/2/26 - Form 6-K
- 1/12/26 - Form 6-K
- 12/8/25 - Form 6-K
- MOLN's page on the SEC website